Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Therapy for isocitrate dehydrogenase 2 (IDH2)R172 -mutant acute myeloid leukaemia.

Journal article

Linch DC. et al, (2022), Br J Haematol, 196, 1348 - 1352

High on-treatment platelet reactivity-an OPTIMAl solution, or a better solution?

Journal article

Hills RK., (2022), Br J Haematol, 196, 272 - 273

Survivin' Acute Myeloid Leukaemia-A Personalised Target for inv(16) Patients.

Journal article

Greiner J. et al, (2021), Int J Mol Sci, 22

Trastuzumab for early-stage, HER2-positive breast cancer: a meta-analysis of 13 864 women in seven randomised trials.

Journal article

Early Breast Cancer Trialists’ Collaborative group (EBCTCG) None., (2021), Lancet Oncol, 22, 1139 - 1150

Diagnosing Diamond-Blackfan anaemia: 'vorsprung durch technik'.

Journal article

Hills RK., (2021), Br J Haematol

Load More